Literature DB >> 21536813

Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomized controlled trial.

Gillian Libby1, Jane Bray, Jennifer Champion, Linda A Brownlee, Janice Birrell, Dermot R Gorman, Emilia M Crighton, Callum G Fraser, Robert J C Steele.   

Abstract

OBJECTIVES: To assess whether pre-notification is effective in increasing uptake of colorectal cancer screening for all demographic groups.
SETTING: Scottish national colorectal cancer screening programme.
METHODS: Males and females aged 50-74 years received a faecal occult blood test by post to complete at home. They were randomized to receive in addition: the pre-notification letter, the pre-notification letter + information booklet, or the usual invitation. Overall, 59,953 subjects were included in the trial between 13/04/09 and 29/05/09 and followed to 27/11/09. Pre-notification letters were posted two weeks ahead of the screening test kit. Uptake was defined as the return of a screening test and chi-squared tests compared uptake between the trial arms. Logistic regression assessed the impact of the letter and letter + booklet on uptake independently of gender, age, deprivation and screening round.
RESULTS: Uptake was higher with both the letter (59.0%) and the letter + booklet (58.5%) compared with the usual invitation (53.9%, p < 0.0001). This increased uptake was seen for males, females, all age groups and all deprivation categories including least deprived females (letter 69.9%, usual invitation 66.6%) and most deprived males (42.6% vs. 36.1%), the groups with the highest and lowest levels of uptake respectively in the pilot screening rounds conducted prior to the roll out of the programme. Uptake with the pre-notification letter compared with the usual invitation was higher both unadjusted and adjusted for demographic factors (odds ratio 1.24, 95% CI 1.193-1.294).
CONCLUSIONS: Pre-notification is an effective method of increasing uptake in colorectal cancer screening for both genders and all age and deprivation groups.

Entities:  

Mesh:

Year:  2011        PMID: 21536813     DOI: 10.1258/jms.2011.011002

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  31 in total

1.  Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.

Authors:  Jessica Chubak; Andy Bogart; Sharon Fuller; Sharon S Laing; Beverly B Green
Journal:  Prev Med       Date:  2013-09-09       Impact factor: 4.018

Review 2.  An update on CT screening for lung cancer: the first major targeted cancer screening programme.

Authors:  David R Baldwin; Matthew E J Callister
Journal:  Br J Radiol       Date:  2020-09-07       Impact factor: 3.039

3.  Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.

Authors:  Jason A Dominitz; Douglas J Robertson; Dennis J Ahnen; James E Allison; Margaret Antonelli; Kathy D Boardman; Maria Ciarleglio; Barbara J Del Curto; Grant D Huang; Thomas F Imperiale; Meaghan F Larson; David Lieberman; Theresa O'Connor; Timothy J O'Leary; Peter Peduzzi; Dawn Provenzale; Aasma Shaukat; Shahnaz Sultan; Amy Voorhees; Robert Wallace; Peter D Guarino
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

4.  Effectiveness of reminder strategies on cancer screening adherence: a randomised controlled trial.

Authors:  Martin Cs Wong; Jessica Yl Ching; Junjie Huang; John Ct Wong; Thomas Yt Lam; Victor Cw Chan; Simpson Kc Ng; Zero Hui; Arthur Kc Luk; Justin Cy Wu; Francis Kl Chan
Journal:  Br J Gen Pract       Date:  2018-08-13       Impact factor: 5.386

5.  Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.

Authors:  Samantha L Quaife; Mamta Ruparel; Jennifer L Dickson; Rebecca J Beeken; Andy McEwen; David R Baldwin; Angshu Bhowmik; Neal Navani; Karen Sennett; Stephen W Duffy; Jane Wardle; Jo Waller; Samuel M Janes
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

6.  Improving uptake of flexible sigmoidoscopy screening: a randomized trial of nonparticipant reminders in the English Screening Programme.

Authors:  Robert S Kerrison; Lesley M McGregor; Sarah Marshall; John Isitt; Nicholas Counsell; Colin J Rees; Christian von Wagner
Journal:  Endoscopy       Date:  2016-12-20       Impact factor: 10.093

7.  Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.

Authors:  Nicola J Hall; Greg P Rubin; Christina Dobson; David Weller; Jane Wardle; Mary Ritchie; Colin J Rees
Journal:  Health Expect       Date:  2013-11-25       Impact factor: 3.377

8.  Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy?

Authors:  Graeme P Young; Callum G Fraser; Stephen P Halloran; Steven Cole
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

9.  The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme.

Authors:  David Mansouri; Donald C McMillan; Yasmin Grant; Emilia M Crighton; Paul G Horgan
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  Gender differences in attitudes impeding colorectal cancer screening.

Authors:  Paul Ritvo; Ronald E Myers; Lawrence Paszat; Mardie Serenity; Daniel F Perez; Linda Rabeneck
Journal:  BMC Public Health       Date:  2013-05-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.